Meperidine hydrochloride
SIGMA/M3142
Synonym: 1-
CAS Number: 50-13-5
Empirical Formula (Hill Notation): C15H21NO2 · HCl
Molecular Weight: 283.79
EC Number: 200-013-3
MDL Number: MFCD00058210
Linear Formula: C15H21NO2 · HCl
Product Type: Chemical
| drug control | kontrollierte Droge in Deutschland |
| USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal) | |
| InChI | 1S/C15H21NO2.ClH/c1-3-18- |
| InChI key | WCNLCIJMFAJCPX-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 200  |
| SMILES string | Cl[H].CCOC(=O)C1(CCN(C)CC |
| Biochem/physiol Actions: | Phenylpiperidine analgesic; sedative; μ opioid receptor agonist with greater κ opioid receptor agonist activity than morphine. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Legal Information: | German Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG. English This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies. |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H336 |
| Precautionary statements | P301 + P310 + P330 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 26-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |